Singapore General Hospital is an academic health science centre as well as a tertiary referral hospital in Singapore, located next to the Bukit Merah and Chinatown districts of the Central Region.

There are 2,000 beds in Singapore General Hospital.

During the past decade, Singapore General Hospital conducted 241 clinical trials. In the 10-year time frame, 241 clinical trials started and 58 clinical trials were completed, i.e. on average, 24.1% percent of trials that started reached the finish line to date. In the past 5 years, 115 clinical trials started and 40 clinical trials were completed. i.e. 34.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Singapore General Hospital" #1 sponsor was "Singapore General Hospital" with 159 trials, followed by "National Cancer Centre, Singapore" with 13 trials sponsored, "Pfizer" with 13 trials sponsored, "Gilead Sciences" with 12 trials sponsored and "National University Hospital, Singapore" with 12 trials sponsored. Other sponsors include 144 different institutions and companies that sponsored additional 101 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Singapore General Hospital" #1 collaborator was "Duke-NUS Graduate Medical School" with 30 trials as a collaborator, "Singapore General Hospital" with 30 trials as a collaborator, "National Medical Research Council (NMRC), Singapore" with 14 trials as a collaborator, "National University Hospital, Singapore" with 13 trials as a collaborator and "Changi General Hospital" with 11 trials as a collaborator. Other collaborators include 231 different institutions and companies that were collaborators in the rest 156 trials.

According to Clinical.Site data, the most researched conditions in "Singapore General Hospital" are "Hepatocellular Carcinoma" (10 trials), "Multiple Myeloma" (9 trials), "Dialysis Access Malfunction" (7 trials), "Stroke" (7 trials) and "Diabetes Mellitus" (6 trials). Many other conditions were trialed in "Singapore General Hospital" in a lesser frequency.

Most popular intervention types in "Singapore General Hospital" are "Drug" (159 trials), "Device" (69 trials), "Other" (65 trials), "Procedure" (27 trials) and "Biological" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Questionnaires" (5 trials), "Filgotinib" (4 trials), "Rituximab" (4 trials) and "Bortezomib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Singapore General Hospital" are 343 trials for "All" genders, 7 trials for "Male" genders and 6 trials for "Female" genders.

Currently, there are 97 active trials in "Singapore General Hospital". 5 are not yet recruiting, 60 are recruiting, 30 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 166 completed trials in Singapore General Hospital, 1 suspended trials, and 27 terminated clinical trials to date.

Out of the total trials that were conducted in Singapore General Hospital, 28 "Phase 1" clinical trials were conducted, 78 "Phase 2" clinical trials and 86 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 84 trials that are defined as “Not Applicable".

Singapore General Hospital has several departments that took part in Clinical trials: "Clinical Trials & Research Unit" - 4 trials, "Singapore General Hospital; Department of Haematology" - 2 trials